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The serum concentrations of the immunoglobulins as with other plasma proteins 
reflect a  balance among their rates of synthesis, rates of catabolism, and patterns of 
distribution. In recent years, a great deal of knowledge has been obtained concerning 
the  synthesis  and  distribution  of  the  plasma  proteins.  However,  relatively  little 
is known of the sites and mechanisms of plasma protein catabolism. 
Using radioio4~nated proteins, it has been shown that each class of immunoglobulins 
is catabolized at its own individual rate, with survival half times varying from 2.8 days 
for the newly discovered IgD to 23 days forIgG (1-6). Moreover, a variety of physio- 
logical  and  pathological  factors  has  been  shown  to  affect  the  survival  of  one 
class,  leaving  the  other  classes  unaffected  (2, 7-9).  These  observations  suggest 
that these proteins are catabolized by processes which are specific for each immuno- 
globulin class and presumably are related to the portion of the immunoglobulin mole- 
cule specific for each class. 
The  results  of  such  studies  indicate  that  immunoglobulins  are  destroyed  by 
a random process in a compartment in rapid equilibrium with the intravascular com- 
partment  (10,  11). However, these studies provide no information as to the specific 
organs  involved  in  catabolism.  Many  other  techniques  have  been  utilized  to 
try to obtain such information, including organ perfnsion (12), organ extirpation (13, 
14),  and  in  vitro  incubation  of  radiolabeled  proteins  with  tissue  slices  (15)  and 
subcelhilar fractions (16). However, no consensus has been reached  regarding a  major 
role for any individual organ in the catabolism of a specific protein. In general, such 
studies are hampered because the time period of the study is usually quite short rela- 
tive to the in vivo life span of the protein, so that it is  necessary to extrapolate re- 
sults to a longer time period. Thus, such methods of study are best applied to proteins 
with very short survival half times. 
In previous work studying the turnover of Bence Jones protein in man, it was shown 
that the survival of the protein was exceedingly short and also that from 50-90% of 
its metabolism was accounted for by endogenous catabolism, the remainder being ex- 
creted  as  proteinuria  (17).  It  was  also  observed  that  the  serum  concentrations 
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and rates of catabolism of the protein were closely correlated with renal function. Im- 
paired renal function was regularly associated with a marked reduction in Bence Jones 
protein catabolism. This could be interpreted  either as an inhibitory effect of uremia 
on  protein  catabolism  or  as  evidence  of  catabolism  of  Bence  Jones  protein  by 
the kidney. 
The current  studies were undertaken  to investigate the role of the kidney  in 
the catabolism of Bence Jones proteins,  intact immunoglobulins,  and immuno- 
globulin subfragments.  The  rates  of catabolism  of iodinated  Bence Jones pro- 
teins, whole immunoglobulins,  and separated L  chains,  Fc piece and Fab piece 
isolated  from  IgG were measured  in  nephrectomized,  ureter-severed,  and  un- 
operated  mice. The kidney was  shown  to play  a  major role in  the catabolism 
of Bence Jones proteins  and isolated L  chains. 
Materials  and Methods 
Animals.--NIH strain mice weighing 20-25 g were used in all experiments. 
Preparation  of Labeled Proteins.-- 
Human IgG:  Human  IgG was  prepared  from  fresh  normal  serum  by  DEAE-eellulose 
chromatography  (2). Serum was dialyzed against 0.005  M, pH 8.0 phosphate buffer, and ap- 
plied to a  DEAE-cellulose (Selectaeel,  Brown Company, Berlin, N. H.) column equilibrated 
and eluted with the same buffer. The protein eluted was shown to be pure IgG as verified by 
immuno-electrophoresis and  the Ouchterlony technique using a  specific  antiserum  directed 
against IgG H  chain and a polyvalent antiserum to whole human serum. 
Normal mouse IgG: Normal mouse IgG was kindly supplied by Dr. Stewart Sell.  It was 
prepared by zone electrophoresis of pooled NIS-WS mouse sera. Serial fractions were eluted 
from the gamma-migrating area of the block and  examined by the Ouchterlony technique 
using a rabbit antiserum against whole mouse serum and an antiserum against the individual 
mouse immunoglobulins. The fractions thus shown to contain IgG free of contaminating pro- 
teins were pooled and concentrated for labeling. 
Human Berne  Jones  proteins:  Ammonium sulfate was added to urine from patients with 
multiple myeloma and X- or ~-type Bence Jones proteinuria until 80% saturation  was ob- 
tained. The mixture was allowed to stand at 4°C for 24 hr and the resultant precipitate then 
redissolved in 0.01 ~  pH 7.6 phosphate buffer. The redissolved protein was then chromato- 
graphed on DEAE-cellulose using the same buffer. The initial peak obtained was shown to 
consist of pure X- or K-Bence Jones protein as verified with the Ouchterlony technique using 
antiserums directed against type-specific L  chain determinants,  H  chain determinants,  and 
whole human serum. 
Mouse Bence Jones  proteins:  Urine from mice bearing the plasmacytoma MPC-2 of Dr. M. 
Potter was dialyzed against 0.005  ~  pH 8.0 phosphate buffer and then chromatographed on 
a DEAE-cellulose column, using a linear gradient from 0.005--0.3 ~  phosphate  (pH 8.0).  The 
initial protein peak was shown  on agar double diffusion  analysis to be pure  mouse Bence 
Jones protein using antiserums directed against mouse L chain, intact mouse immunoglobulins, 
and whole mouse serum. 
Human L chains: L chains were prepared by reduction and aikylation (18). Human Cohn 
fraction II, IgG, was subjected to reduction with 0.1 ~/3-mercaptoethanol at pH 8.0 (tris-HCl 
buffer). Alkylation was initiated after 1 hr with the addition of cold 0.1 M iodoacetamide. The 
mixture was then dialyzed against cold distilled water (4 hr) and, finally, against 1.0 ~  acetic 
acid. L  chains were isolated by Sephadex  G-130  (mixture of Sephadex  G-200  and  G-100) 
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pure L chains free of H  chains with specific anti-K- and anti-X-L chain antiserums as well as 
specific anti-H chain antiserum in Ouchteflony analysis. 
Rabbit Fc piece: Rabbit Cohn fraction II was purified by passage through a DEAE-cellulose 
column equilibrated with pH 6.3, 0.01 •  phosphate buffer. Papain digestion was then carried 
out on the purified material according to the method of Porter (19). Digestion was performed 
at pH 7.5 (0.1 ~t phosphate) in the presence of papain (1 rag/100 mg protein), cysteine (0.02 ~t), 
and EDTA (0.02 xt); digestion was carried out for 1~ hr at 37°C,  and the reaction was ter- 
minated by dialysis in the cold against 0.03 ~t borate pH 8.4 buffer containing 0.001 M  p-chloro- 
mercuribenzoate.  Fc fragment  crystals formed in the dialysis bag and  were separated  and 
redissolved in 0.1 ~  acetate pH 5.0. A second crystallization was then accomplished against 
the borate buffer and the crystallized material again dissolved in pH 5.0 acetate. The Fc frag- 
ment  thus obtained was tested with specific  anti-H chain and anti-L chain antiserums  in 
Ouchterlony analysis and shown to be uncontaminated with L chain determinants. 
Rabbit Fob fragment: The supernatant  solution obtained after the above described papain 
digestion and precipitation of Fc fragment was dialyzed against 0.01 ~ pH 5.8 acetate buffer 
and  chromatographed  on carboxymethyl  (CM)  cellulose using the same buffer. The initial 
peak was obtained and  shown to contain only Fab fragment using antisera to the H  or L 
chains or to the Fc piece of IgG. 
Iodination of the proteins: Each of the purified proteins was labeled with xslI by the iodine 
monochloride technique of McFarlane (20). There was from 0.3 to 1.0 moles of iodine per mole 
of protein in each of the final products. Over 98% of the radioactivity of all preparations was 
precipitable by 20% phosphotungstic acid. 
Method of measuring protein catabolism: Protein catabolic rates  are usually determined 
from the rate of decline of radioactivity in the whole animal or in the serum following an 
intravenous  dose  of radioiodinated  protein.  The basic assumptions  of these techniques as 
usually performed are that radioiodine released on protein catabolism be quantitatively ex- 
creted from the body, and that the rate of protein catabolism be slow relative to the rates of 
protein distribution between body compartments and to the rates of excretion of the radio- 
active catabolic products from the body. With very rapidly catabolized proteins such as Bence 
Jones proteins or with any protein in nephrectomized or ureter-severed animals these require- 
mints are not fulfilled, and so different techniques must be used. 
The technique used in the present study was chosen to circumvent the problems imposed 
by delayed or absent excretion of released radioiodide from the body. Catabolism was assessed 
by determining the rate of decline in protein-bound  (acid-preeipitable)  radioactivity of the 
whole body with time. The protein-bound radioactivity of the body was estimated by measur- 
ing the protein-bound activity of aliquots of whole homogenized animals killed at appropriate 
intervals after injection of the labeled proteins. The fraction of the radioactivity remaining 
protein bound is the fraction of the injected protein not yet catabolized. 
Experimental protocol: All mice were maintained on drinking water containing potassium 
iodide (0.6 g/liter) for at least 2 days prior to their use to block thyroidal uptake of released 
radioiodide.  In each experiment 60-80  mice were placed in three groups:  nephrectomized, 
ureter-llgated or ureter-severed, and unoperated controls. Operated animals were anesthetized 
with chloral hydrate and ether. Bilateral nephrectomies were performed through flank inci- 
sions,  and the ureters were severed or ligated bilaterally using a midabdominal incision. The 
animals wereinjeeted with I-2 #c of the 131I-labeled protein within an hour after surgery unless 
otherwise noted. At timed intervals, 3-6 animals from each group were killed and the fraction 
of the injected labeled protein that had been catabolized was determined as follows: 
For nephrectomized and ureter-operated animals, no excretion of radioactivity to the out- 
side was possible.  After these  animals were killed,  their carcasses  were homogenized in a 
Waring Blendor along with 200 ml of water. Duplicate 3-ml aliquots of the homogenate were 210  RENAL  CATABOLISM  O~"  BENCE  JONES  PROTEINS 
removed. The protein of one aliquot was precipitated by the addition of an equal volume of 
20% phosphotungstic acid. The precipitated preparations were filtered and the clear super- 
natants were counted at the same time as the untreated homogenate aliquots in an automatic 
well-type gamma counter. The fraction of the total radioactivity which was protein bound 
was thus determined. For these animals, this fraction is equivalent to the fraction of injected 
protein which was not yet catabolized. 
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FIe. 1.  Plasma and whole-body survival of human Bence Jones protein in the mouse. At 
6 hr, when 17% of the injected radioactivity remained protein bound in the body, less than 
0.5% of the injected activity was found within the plasma. 
Urinary excretion of radioactivity could occur in the unoperated animals. The radioactivity 
in these animals was measured immediately after injection of the radioiodinated protein and 
again after the animals were killed using a  small animal bulk counter. The fraction of the 
initial radioactivity remaining in the carcass was determined from these measurements. The 
carcasses were then processed as described above. It was thus possible to determine the frac- 
tion of the initial injected radioactivity which remained protein bound within the body at the 
time of death of the animals. This figure was calculated as the product of the fraction of the 
initial radioactivity remaining in the carcass and the fraction of this radioactivity which was 
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The fraction of injected protein remaining protein bound (uncatabolized) was thus obtained 
for each mouse. The values for from three to six animals killed at each time point were averaged 
and plotted on semilogarithmic graph paper against time (Figs. 1-7). 
In unoperated  animals the relative contributions of endogenous catabolism and  urinary 
loss of intact protein were determined according to the method of Gitlin et al. (21). This tech- 
tO0 
90 
80 
___  70 
~  6o 
~  5o 
w  40 
{O 
0 
r'., 
3O 
ILl 
I.-.. 
0 
z  \ 
\ 
\ 
--  o --  Nephrectomized 
•  Ureter-Ligoted 
__,.,=-__ Unoperoted Controls 
TIME  (Hours) 
Fzo. 2.  Survival of human type K-Bence Jones protein in the mouse. The catabolism of 
Bence Jones protein was found to be markedly impaired in nephrectomized animals. 
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FIG. 3.  Survival of human IgG in the mouse. The rate of catabolism of IgG was comparable 
in nephreetomized, ureter-severed, and control mice. 
nique depends on the fact that all of the radiolabel excreted as a result of endogenous catab- 
olism ultimately appears in the urine as iodide or iodinated tyrosine and is not precipitable 
with phosphotungstic add, while radioLabel excreted as proteinutia is precipitable with acid. 
Accordingly, at a  time when essentially all of the injected radioactivity has been excreted, 
the cumulative excretion of acid-soluble radioactivity compared to that of add-precipitable 
radioactivity provides a  reliable estimate of the relative contributions of endogenous catab- 
olism and proteinutia. Thus, unoperated animals were placed in metabolic cages after injec- 
tion, and  an urine was collected until excretion of radioactivity was for practical purposes 212  RENAL  CATABOLISM  OF BENCE  JONES  PROTEINS 
complete. The cages were rinsed with saline and aiiquots of the combined urine and washings, 
along with added albumin as a  carrier protein, were precipitated with 20% phosphotungstic 
acid, and counted as described above for mouse homogenates. The ratios of nonprecipitable 
to total and precipitable to total radioactivity in the urine were taken as estimates of the rela- 
tive  contributions of  endogenous catabolism and  proteinuria,  respectively,  to  the  overall 
metabolism of the protein. The whole-body metabolic rate  (catabolic plus proteinuric rate) 
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FzG. 4.  Survival of human L  chains in the mouse. The catabolism of L  chains was found 
to be markedly impaired in nephrectomized animals.  ,oo  
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FIG. 5.  Survival of rabbit Fc fragment in mouse. The Fc portion of the H  chain of rabbit 
]EgG was catabolized at the same rate in ureter-severed and nephrectomized groups. R.  DEAN  WOCHNER,  WARREN  STROBER~ THOMAS A.  WALDMANN  213 
was estimated for control animals by dividing the loge 2  (0.693) by the survival half time, 
estimated graphicaUy from the protein-bound radioactivity curves. The proteinuric rate and 
the catabolic rate were calculated by multiplying this whole-body metabolic rate by the frac- 
tion  of  the  overaU metabolism  accounted  for  by  proteinuria  and  endogenous  catabolism 
respectively. 
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FIG. 6.  Survival of rabbit Fab fragment in mouse. The rate of catabolism of Fab piece was 
only slightly less  in nephrectomized animals compared  to ureter-severed animals,  but  was 
much less in these groups than in non-uremic control auimals. 
Validity of methodology: The release of iodine from iodinated protein in vivo has been shown 
to provide a  valid measure of protein catabolism  (10).  Using the present technique it is also 
required that there be no coprecipitation of iodine with protein on treatment with phospho- 
tungstic add, nor should iodide be reincorporated into protein once released. Similarly, it is 
required that no deiodination of the protein occur during the homogenization and precipitation 
procedures. These requirements were fulfilled as shown by the following studies: 
1.  Six ureter-severed and  six control mice who had  received potassium  iodide in  their 
drinking water for 48 hr were given sodium-181I intravenously.  18 hr later, they were kitled, 
homogenized, and the precipitability of the radioactivity determined as discussed  above. In 
each case 98-100%  of the radioactivity was nonprecipitable,  indicating  that  no significant 
coprecipitation or reincorporation of the radiolabd took place. 214  RENAL  CATABOLISM  OF  BENCE  JONES  PROTEINS 
2.  To evaluate the effect of homogenization and subsequent handling of the samples on 
protein binding of iodine, four to six animals were injected with each preparation, immedi- 
ately killed, and then processed in the same manner as the other experimental animals. For 
each preparation 98-100% of the radioactivity was precipitable. Thus, no radiolabel was re- 
leased from the protein during handling of the sample. 
It will be seen that the decline of protein-bound activity of the whole-body after injection 
of Bence Jones protein was not linear with time but tended to have a progressive decrease in 
slope. A similar decrease in slope was seen in a previous study of Bence Jones metabolism in 
man (17). Three possible explanations for thisphenomenon wereconsidered, including (a) rein- 
corporation of  radioiodine into proteins,  (b)  contamination of  the protein injected with a 
slowly catabolized radiolabeled protein, or (c) transfer of radiolabeled protein from the cata- 
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FIo.  7.  Survival of human Bence Jones protein in groups of ureter-severed mice injected 
within 1 hr or at 18 hr after operation. The uremic mice injected 18 hr after the surgical pro- 
cedure catabolized Bence Jones protein at a much slower rate than animals injected within 1 
hr of the procedure. 
bolic pool (intravascular pool or a pool in rapid equilibrium with it) to a slowly equilibrating 
extravascular noncatabolic pool. Reincorporation of iodide into protein was  excluded by the 
administration of Na 1~I in the studies discussed above. To test the other possibilities, a group 
of control mice was injected with 131I Bence Jones protein and handled in the usual manner 
except that protein-bound plasma radioactivity was also determined at the time of sacrifice 
for all animals. The specific  activity (cpm/ml) of plasma was obtained and plotted against 
time as a percentage of the plasma activity present 5 rain after injection. No decrease in slope 
of the serum curves was observed as would have been seen ff a slowly catabolized protein con- 
taminant had been injected (Fig. 1). At 6 hr, when 17% of the injected radioactivity remained 
protein bound in the body,  less than 0.5%  of the injected activity was found within the 
plasma. Thus, more than 97% of protein-bound activity was located in the extravascular space 
at that time. The protein-bound radioactivity in various organs (spleen, kidney, liver, lung, 
thyroid, gastrointestinal tract, and carcass with viscera removed) was also determined at 6 hr 
after injection of the iodinated Bence Jones protein. Over 80% of the precipitable radioactivity R.  DEAN  WOCHNER,  wARREN  STROBER,  THOMAS A.  WALDMANN  215 
was in the carcass with viscera removed. These studies suggest that the progressive decrease 
in slope of the whole-body  radioactivity curves was secondary to distribution of the labeled 
protein into extravascular (skin, muscle) noncatabolic  pools. 
RESULTS 
The half times of protein survival (T  J/6) and the relative roles of proteinuria 
and catabolism in the overall metabolism of IgG, type g- and X-human Bence 
Jones proteins, mouse Bence Jones protein, isolated L  chains,  Fc piece, and 
Fab piece are shown in Table I. The major factor in the overall metabolism 
of each of the proteins studied was found to be endogenous catabolism, with 
proteinuria a less significant factor. This was true even for Bence Jones proteins, 
with catabolism accounting for 75-82 % of the overall metabolism. 
TABLE I 
The  Protelnuric  and  Catabolic  Rates  of Iramunoglobulin  and  Subfragment  Moleeules 
Protein 
IgG (human) 
Bence Jones protein 
Human (type K) 
Human (type X) 
Mouse (MPC-2) 
L chain  (human IgG) 
Fc piece  (rabbit) 
Fab piece  (rabbit) 
Half time  of 
survival 
kr 
88 
1.4 
0.8 
1.0 
1.0 
39 
3.6 
Proteinurlc  rate 
%bodypool/hr 
0 
9 
22 
14 
Not done 
0.3 
7 
Catabolic rate 
% body pool/kr 
0.8 
40 
65 
54 
Not done 
1.5 
12 
Overall 
metabolism 
due to catabolism 
% 
100 
82 
75 
79 
Not done 
83 
63 
The catabolism of Bence Jones protein was found to be markedly impaired 
in nephrectomized animals. Control animals catabolized 50 % of the K-human 
Bence Jones protein in 1.4 hrs after intravenous injection, while nephrectomized 
animals did not do so until 17 hr after injection (Fig. 2, Table II). Ureter-ligated 
and ureter-severed animals catabolized 50 %  of the administered Bence Jones 
protein by 1.6 hr; thus the operative procedure, early uremia, and the preven- 
tion of loss of Bence Jones protein in the urine did not significantly affect Bence 
Jones metabolism.  It should be noted that  ureter-severed and ureter-ligated 
animals behaved identically in their metabolism of Bence Jones proteins. Simi- 
lar results were obtained using type X human Bence Jones protein and Bence 
Jones protein isolated from the urine of mice bearing the MPC-2 plasma cell 
tumor.  In  each case  the  control and  ureter-severed animals  catabolized the 
Bence Jones protein at 5-10 times the rate observed in nephrectomized animals 
(Table II). In contrast, there was no significant difference between groups of 
control, ureter-severed, and nephrectomized mice in the rate of catabolism of 216  RENAL  CATABOLISM  OF  BENCE  JONES  PROTEINS 
intact IgG from either human or mouse origin (Fig. 3, Table II).  These results 
indicate that the kidney plays a major role in the catabolism  of Bence Jones 
proteins but not of intact IgG. 
Because of the structural relationships  between  IgG and Bence Jones pro- 
teins, it was of interest to study the metabolism of IgG fragments, including L 
chains, Fc piece, and Fat) piece. The catabolism of L chains isolated from pooled 
human IgG was found to be comparable to that of Bence Jones proteins. While 
ureter-severed  and  unoperated  controls  catabolized  50%  of  the  injected L 
chains in 1.9 and 1.0 hr, respectively, nephrectomized animals did not do so for 
9.5 hr (Table II, Fig. 4). In contrast, the Fc portion of the H chain of rabbit 
TABLE  II 
Effect  of Nephrectomy  and  Ureter Severing  on  the  Catabolism  of Immunoglolndins  and 
Sub  fragments 
Protein 
Bence Jones protein 
Human (type ~) 
Human (type k) 
Mouse MPC-2 
IgG (human) 
IgG (mouse) 
L chain (human IgG) 
Fc piece (rabbit) 
Fab piece (rabbit) 
Time for catabolism  of 50% of the injected dose 
Unoperated 
control 
hr 
1.4 
0.8 
1.0 
88 
60 
1.0 
39 
3.6 
Ureter- 
severed 
kr 
1.6 
1.4 
1.5 
86 
58 
1.9 
76 
11.3 
Nephrectomized 
hr 
17 
9 
10 
88 
60 
9.5 
76 
13.5 
IgG was metabolized  at the same rate in ureter-severed  and nephrectomized 
groups (Fig. 5). This rate was somewhat slower than that observed in control 
animals, in part due to the elimination of direct urinary loss of intact Fc piece 
(Table II) and in part possibly due to the effects of uremia. The rate of catabo- 
lism of the rabbit Fab piece  (consisting  of the Fd fragment of the H  chain 
attached to an L chain) was slightly less in nephrectomized  animals compared 
to ureter-severed  animals (Fig. 6). 
These results indicate that the kidney is required  for normal catabolism of 
L chains and Bence Jones proteins,  which are dimers of L chains, but that it 
does not appear to be required for catabolism of intact IgG, Fc piece, or prob- 
ably of Fab piece. 
The presence of advanced uremia was associated with impairment of Bence 
Jones protein catabolism.  All of the foregoing studies were performed  using 
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when ureter-severed  or ureter-ligated animals  were  injected 18  hr  after the 
surgical procedure, they catabolized Bence Jones protein at a much slower rate 
than animals injected within 1 hr of the procedure  (Fig. 7). It should also be 
noted that both ureter-severed  and nephrectomized  animals catabolized  Fab 
piece (Fig. 6) and to a lesser degree Fc piece (Fig. 5), at a much slower rate 
than control animals or sham-operated animals,  suggesting that even "early" 
uremia may inhibit the catabolism of these molecules. 
DISCUSSION 
Bence Jones protein and isolated L  chains are broken down rapidly by an 
endogenous catabolic process which is quantitatively of much more importance 
in their overall metabolism than loss in the urine as intact proteins.  This cata- 
bolic process is markedly impaired in nephrectomized  mice, but not in those 
with bilateral ureteral interruption, indicating that catabolism  is  dependent 
upon the presence of renal tissue, and probably takes place within the kidney. 
Whole IgG molecules, the Fc immunoglobulin fragment, and to a lesser extent 
the Fab fragment, do not participate in this process since these molecules have 
the same  survival  in nephrectomized  and ureter-severed  animals.  The  cata- 
bolic  process  is impaired in the presence of advanced uremia as indicated by 
prolonged  survival  of Bence  Jones proteins  in  ureter-severed  animals that 
were not injected until 18 hr after surgery. 
Previous work had indicated that the kidneys do not play a significant role 
in the catabolism of albumin except possibly in the presence of severe nephrosis 
(13, 23). In some animals with experimental  nephrosis, nephrectomy decreases 
the fractional catabolic  rate for albumin.  In these  animals there is increased 
filtration of albumin through the glomerulus exposing the protein to the renal 
tubular cells. It has been suggested that the filtered albumin may be absorbed 
and catabolized by the tubular cells (23). It should be noted that large quanti- 
ties of albumin must be present in the filtrate before renal catabolism  of albu- 
min can be demonstrated. In the current study, it might be speculated  that 
Bence Jones proteins and L  chains  are also filtered  and then catabolized  by 
the tubular cells since these are small  molecules (mol wt  <  45,000) and their 
appearance in the urine is proof that they are exposed to the tubular epithe- 
lium. However, the rabbit Fc and Fab immunoglobulin fragments are also small 
and appear in the urine and so must be exposed to the tubule.  Yet these pro- 
teins are not catabolized significantly by the kidney. Similarly, no renal catabo- 
lism was observed for another immunoglobulin fragment appearing in the urine 
of mice with MOPC-20-plasma  cell tumors. This molecule contains parts of 
both L and H chains of mouse IgA. Thus, the mere presence of protein in the 
renal tubule is not sufficient for significant protein catabolism  to take place. 
Furthermore, ureter-severed  and ureter-ligated mice  were  identical in  their 
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glomerular filtration abruptly. Thus, although the mechanism by which renal 
catabolism takes place in the intact animal may involve filtration of the protein 
and reabsorption by the tubular cells, glomerular filtration does not appear to 
be an absolute requirement for this catabolism to take place. 
Many previous observations have defined reactions of transport and metabo- 
lism of immunoglobulins which appear  to be  related most closely to the Fc 
portion of the immunoglobulin molecule (1-9). In the current study, it is the 
L chain moiety which appears to be susceptible to the renal catabolic process. 
The combination of H  chains and L  chains in the form of an intact immuno- 
globulin molecule was not susceptible  to  renal  catabolism and  only partial 
susceptibility could be demonstrated for the rabbit Fab piece containing the L 
chain and just the Fd portion of the H chain. The remainder of the H chain, as 
the Fc piece, was unaffected by the catabolic process.  Thus, another metabolic 
reaction is demonstrated which is related to a specific portion of the immuno- 
globulin molecule, the L  chain moiety. Whether attachment of the tt chain 
inhibits access to a catabolic site, inhibits the catabolic process itself, or possibly 
acts by some other mechanism will require further study. 
Proteinuria is a  frequent concomitant of renal disease and may be of two 
major types. The most common is typified in its severe form by the nephrotic 
syndrome. Here the urinary proteins represent a  filtrate of the plasma, with 
smaller proteins such as albumin appearing in greater quantities than the larger 
ones (24). This type of protein loss appears to be a result of glomerular damage, 
with leakage of excess protein into the tubule resulting in proteinuria. The other 
major type of proteinuria occurs in subjects with disease predominantly affect- 
ing the renal  tubules such as renal tubular acidosis or the Fanconi syndrome 
(25).  In this situation, the proteins excreted are not simply a  filtrate of the 
plasma. Instead, the urine contains relatively little albumin, but a variety of 
other proteins are observed. Most of these are as yet unidentified, but they are 
of low molecular weight and migrate predominantly in the  alpha and beta 
regions on electrophoresis. The pathogenesis of this type of proteinuria is not 
yet clear. It may be that these proteins appear in the urine because of failure 
of the tubules to reabsorb and catabolize proteins that are filtered. The current 
observations demonstrate that  at least some proteins  (Bence Jones proteins 
and isolated L chains) may be catabolized by the kidney, thus lending indirect 
support to this hypothesis. 
The recovery of Bence Jones proteins from the urine has now been recognized 
as a major sign of disease for more than a century (26). In recent years, L chains 
have also been recovered in urine of normal individuals, but their significance 
is still unclear (27-29).  Isotopic studies suggest that they are products of de 
nova synthesis and not breakdown products of immunoglobulins (29, 30).  It is 
clear from the current and previous studies (17) that the quantity of either L 
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indication of the rate of production of these substances. Rather, they are syn- 
thesized at rates considerably greater than the rate of urinary loss would indi- 
cate,  the  remainder  being  catabolized within  the  kidney.  Furthermore,  the 
presence  of  renal  disease  and  uremia  impairs  this  catabolic  process.  Thus, 
patients with multiple myeloma who have renal  disease may have a  signifi- 
cantly reduced rate of catabolism of Bence Jones protein that contributes to the 
development of detectable serum levels  of Bence Jones protein.  It  may be 
predicted that  other diseases  associated with renal dysfunction will be found 
in which altered metabolism of L chains occurs. Indeed, one recent observation 
of increased serum concentrations of L chains in systemic lupus erythematosis 
(31) may be such an instance, although no correlation could be made between 
the increase in L chain concentration and the presence of azotemia in these pa- 
tients. Other diseases, especially those with renal tubular dysfunction, will bear 
further investigation in this regard. 
SUMMARY 
The role of the kidney in the catabolism of Bence Jones proteins, intact IgG 
molecules,  and isolated L  chains,  Fab and Fc fragments of IgG, was studied. 
The proteins were purified,  radioiodinated, and their survival times measured 
in nephrectomized, ureter-severed, and control mice. 
Active endogenous catabolism was the major factor in overall Bence Jones 
metabolism since excretion as proteinuria accounted for less than 25 % of the 
total metabolism. The survival times of k- and K-type human Bence Jones pro- 
teins and the Bence Jones protein produced by mice with MPC-2 plasma cell 
tumor were exceedingly short in both unoperated and ureter-severed mice, with 
50 % of the injected protein catabolized in from 0.8-1.6 hr.  In contrast~  the 
survival  of Bence Jones protein was markedly prolonged in nephrectomized 
animals,  with 50% of the injected dose catabolized in from 9 to 17 hr. This ten- 
fold decrease in catabolic rate indicates that the kidneys are the major site of 
breakdown of Bence Jones proteins. Similar  studies with other proteins indi- 
cated that the kidneys are also the major site for catabolism of isolated L chains 
but not of intact IgG molecules.  The Fc immunoglohulin  fragment was not 
catabolized and  the Fab fragment only partially catabolized by the kidney. 
When ureter-severed animals were allowed to develop advanced uremia before 
being studied, the survival of Bence Jones protein was greatly prolonged,  indi- 
cating that  the catabolic process is impaired in the presence of uremia.  The 
nature of this renal catabolism remains unknown. 
These observations suggest that the Bence Jones proteins and L chains ob- 
served in the urine of patients may reflect only a small fraction of such molecules 
synthesized by these patients. Furthermore, they provide an explanation for the 
prolongation  of Bence Jones protein survival and  the development of Bence 220  RENAL  CATABOLISM  OF BENCE  JONES PROTEINS 
Jones proteinemia observed in subjects with multiple myeloma and impaired 
renal function. 
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